“Clinical trials referral resource. Clinical trials of dolastatin-10.”, Oncology (Williston Park), vol. 13, no. 1, pp. 68-70, 75, 1999.
, “Immunization with envelope MN rap 120 vaccine in human immunodeficiency virus infected pregnant women”, J Infec Dis, vol. 180, pp. 1080-8, 1999.
, “Clinical trials referral resource. Current clinical trials of bortezomib.”, Oncology (Williston Park), vol. 17, no. 5, pp. 677-80, 683-6, 691-2, 2003.
, “Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness.”, Allergy, vol. 71, no. 11, pp. 1552-1560, 2016.
, “Implementation of a Medication and Supply Inventory and Resupply Process - Increasing the Efficiency of the Tracking and Distribution of Supplies in Clinical Trials”, in Society for Clinical Trials (SCT) 36th Annual Meeting (2015), Arlington, VA, 2015.
, “Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra).”, Oncology (Williston Park), vol. 16, no. 7, pp. 930-1, 935-7, 2002.
, “Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research G”, Ophthalmology, vol. 124, no. 4, pp. 479-487, 2017.
, “Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.”, JAMA Intern Med, vol. 174, no. 5, pp. 763-71, 2014.
, “Testing and linkage to HIV care in China: a cluster-randomised trial.”, Lancet HIV, vol. 4, no. 12, pp. e555-e565, 2017.
, “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.”, Contemp Clin Trials, vol. 50, pp. 90-7, 2016.
, “Design of the Buprenorphine Physician-Pharmacist Collaborative Care of Patients with Opioid Use Disorder. ”, in 81st Annual Scientific Meeting of the College of Problems on Drug Disorders (CPDD), , San Antonio, TX. , 2019.
, “DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.”, Drug Alcohol Depend, vol. 179, pp. 42-46, 2017.
, , , “Impact of Antioxidants, Zinc, and Copper on Cognition in the Elderly: A Randomized, Controlled Trial”, Neurology, vol. 63, pp. 1705-1707, 2004.
, “Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.”, Neurology, vol. 63, no. 9, pp. 1705-7, 2004.
, , “Induction of human T-Cell-Mediated immune responses after primary and secondary smallpox vaccination”, J Infectious Diseases, vol. 190, pp. 1286-94, 2004.
, “Genome-wide analysis of disease progression in age-related macular degeneration.”, Hum Mol Genet, vol. 27, no. 5, pp. 929-940, 2018.
, “Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials ne”, Biol Blood Marrow Transplant, vol. 20, no. 6, pp. 858-64, 2014.
, “Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol”, Biol Blood Marrow Transplant, vol. 20, pp. 858-864, 2014.
, “Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.”, Nat Med, vol. 9, no. 4, pp. 416-23, 2003.
, “Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning”, Nature Medicine, vol. 9, pp. 416-423, 2003.
, “Optimizing an Existing Data Collection System for Tablet Compatibility: Considerations and a Case Study”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
, “Operational Data Management within the Clinical Trials Network of the National Institute on Drug Abuse (NIDA CTN)”, in 20th Annual Conference of the Society for Clinical Data Management, Las Vegas, NV, 2014.
,